Author

Konrad Bochennek

Goethe University FrankfurtORCID 0000-0002-6881-6511Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:scATAC-seq· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Andrea Wittmann· 1 shared Andrey KorshunoviD· 1 shared Anne RademacheriD· 1 shared Barbara JonesiD· 1 shared Britta Statz· 1 shared Christian ReimanniD· 1 shared Cornelis Martinus van TilburgiD· 1 shared D. T. W. JonesiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrea Wittmann

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNaturePeer-reviewedMay 7, 2025

Medulloblastoma oncogene aberrations are not involved in tumor initiation, but essential for disease progression and therapy resistance

Konstantin Okonechnikov, Piyush K. Joshi, Verena Körber…·Stefan Michael Pfister

The paper uses single-cell technologies to show that large-scale chromosomal aberrations drive medulloblastoma initiation, while single-gene oncogenic events like MYC contribute to progression and therapy resistance.

27 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky